Search

Your search keyword '"Castellví-Bel, Sergi"' showing total 485 results

Search Constraints

Start Over You searched for: Author "Castellví-Bel, Sergi" Remove constraint Author: "Castellví-Bel, Sergi"
485 results on '"Castellví-Bel, Sergi"'

Search Results

1. CTNND1 is involved in germline predisposition to early-onset gastric cancer by affecting cell-to-cell interactions

2. Fine-mapping analysis including over 254,000 East Asian and European descendants identifies 136 putative colorectal cancer susceptibility genes

4. Combining Asian and European genome-wide association studies of colorectal cancer improves risk prediction across racial and ethnic populations

5. Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries

6. Genetically predicted circulating concentrations of micronutrients and risk of colorectal cancer among individuals of European descent: a Mendelian randomization study

7. Elucidating the Risk of Colorectal Cancer for Variants in Hereditary Colorectal Cancer Genes

8. BMPR2 as a Novel Predisposition Gene for Hereditary Colorectal Polyposis

10. Identification of potential mediators of the relationship between body mass index and colorectal cancer: a Mendelian randomization analysis

11. Author Correction: Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries

12. Identifying Novel Susceptibility Genes for Colorectal Cancer Risk From a Transcriptome-Wide Association Study of 125,478 Subjects

13. Data-Independent Acquisition Mass Spectrometry Analysis of FFPE Rectal Cancer Samples Offers In-Depth Proteomics Characterization of the Response to Neoadjuvant Chemoradiotherapy

14. Identifying metabolic features of colorectal cancer liability using Mendelian randomization

15. Author Response: Identifying metabolic features of colorectal cancer liability using Mendelian randomization

16. Performance and Dimensionality of Pretreatment MRI Radiomics in Rectal Carcinoma Chemoradiotherapy Prediction

18. Performance and Dimensionality of Pretreatment MRI Radiomics in Rectal Carcinoma Chemoradiotherapy Prediction.

19. Endoscopic surveillance for familial intestinal gastric cancer in low‐incidence areas: An effective strategy.

20. Reply

21. Exploring novel genetic and hematological predictors of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer

22. Elucidating the Risk of Colorectal Cancer for Variants in Hereditary Colorectal Cancer Genes

23. Identification of a Novel Candidate Gene for Serrated Polyposis Syndrome Germline Predisposition by Performing Linkage Analysis Combined With Whole-Exome Sequencing

24. Discovery of common and rare genetic risk variants for colorectal cancer

26. Adiposity, metabolites, and colorectal cancer risk: Mendelian randomization study

27. Case-control study for colorectal cancer genetic susceptibility in EPICOLON: previously identified variants and mucins

28. Supplementary Figures and Table from BRIP1, a Gene Potentially Implicated in Familial Colorectal Cancer Type X

29. Data from BRIP1, a Gene Potentially Implicated in Familial Colorectal Cancer Type X

30. Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis

31. Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study

32. Supplementary Methods from MLH1 Founder Mutations with Moderate Penetrance in Spanish Lynch Syndrome Families

33. Data from MLH1 Founder Mutations with Moderate Penetrance in Spanish Lynch Syndrome Families

34. Supplementary Figure 1 from MLH1 Founder Mutations with Moderate Penetrance in Spanish Lynch Syndrome Families

35. Supplementary Table 1 from MLH1 Founder Mutations with Moderate Penetrance in Spanish Lynch Syndrome Families

36. Supplementary Table 2 from MLH1 Founder Mutations with Moderate Penetrance in Spanish Lynch Syndrome Families

37. Pancreatic Cancer Surveillance in Carriers of a Germline Pathogenic Variant in CDKN2A

38. Unraveling the impact of a germline heterozygous POLD1 frameshift variant in serrated polyposis syndrome

39. Combining Asian-European Genome-Wide Association Studies of Colorectal Cancer Improves Risk Prediction Across Race and Ethnicity

40. Validation of a Genetic-Enhanced Risk Prediction Model for Colorectal Cancer in a Large Community-Based Cohort

41. Evidence for genetic association between chromosome 1q loci and predisposition to colorectal neoplasia

42. Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries

44. Evaluating the Potential of Polygenic Risk Score to Improve Colorectal Cancer Screening

45. Tu1100: HETEROZYGOUS MUTATIONS IN DNA REPAIR GENES CONFER GENETIC SUSCEPTIILITY TO COLORECTAL CANCER AMONG LYNCH-LIKE CASES

46. Evaluating the Potential of Polygenic Risk Score to Improve Colorectal Cancer Screening

47. Microbiome Profiling from Fecal Immunochemical Test Reveals Microbial Signatures with Potential for Colorectal Cancer Screening.

48. Editorial: Innovative translational research to identify colorectal cancer biomarkers for personalized medicine.

49. Identification of Lynch Syndrome Carriers among Patients with Small Bowel Adenocarcinoma

50. Salicylic Acid and Risk of Colorectal Cancer: A Two-Sample Mendelian Randomization Study

Catalog

Books, media, physical & digital resources